Recent advancements in mitochondrial donation have allowed for healthy births in families affected by mitochondrial disorders, offering hope and freedom from genetic fate. This scientific breakthrough combines parental nuclear DNA with healthy mitochondria from a donor, leading to a significant change in human inheritance while raising ethical considerations regarding genetic modifications. The development emphasizes the importance of a careful regulatory framework to ensure responsible application of such technologies.

The article discusses the emerging trend of genetic selection for embryos, highlighting the company Orchid, which offers parents the option to choose their future child's genetic traits through testing. It raises important moral and ethical questions about the implications of separating reproduction from traditional methods and the potential impact on society.